BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. (BGLC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BGLC · as of Sep 30, 2025
Ownership Breakdown
2
Institutional Holders
▲ 1 vs Q2
$121,854
Total Inst. Value
▲ $92,499 vs Q2
2.01M
Shares Outstanding
freeFloat 64.41%
22,277
13F Shares Held
▲ 12,715 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BGLC largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 2 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
DRW SECURITIES, LLC services-medical laboratories | 14.7K | 81.55% | 81.55% | $80.14M | Nov 14, 2025 | NEW |
UBS GROUP AG services-medical laboratories | 7.6K | 42.45% | 42.45% | $41.71M | Nov 13, 2025 | ▼ 1.9K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
0
Increased
+0 shares1
New Positions
first time holders1
Decreased
−1.9K shares0
Sold Out
fully exitedNet shares change (top 50)
1.9K
+0 / −1.9K
Net new holders
+0
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BGLC insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
BioNexus Gene Lab Corp. (BGLC) is primarily owned by institutional investors, who hold approximately 1.1% of total shares outstanding. Company insiders own approximately 35.59%, while retail and public investors account for the remaining 63.31%.
The largest institutional shareholder of BioNexus Gene Lab Corp. is DRW SECURITIES, LLC, holding approximately 14,651 shares — equal to 81.55% of outstanding shares — as of September 30, 2025.
A total of 2 institutional investors currently hold BGLC stock, with a combined institutional value of approximately $121,854 as of the most recent 13F filing period.
Frequently asked questions
BGLC ownershipBioNexus Gene Lab Corp. (BGLC) is primarily owned by institutional investors, who hold approximately 1.1% of shares. The largest shareholder is DRW SECURITIES, LLC with a 81.55% stake. Company insiders hold 35.59%. Data sourced from SEC Form 13F as of September 30, 2025.